These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9368218)

  • 21. Fenfluramine and phentermine.
    Howlin D
    Ann Intern Med; 2001 Nov; 135(9):840-1. PubMed ID: 11694113
    [No Abstract]   [Full Text] [Related]  

  • 22. Phentermine pretreatment antagonizes the cocaine-induced rise in mesolimbic dopamine.
    Rothman RB; Ayestas M; Baumann MH
    Neuroreport; 1996 Dec; 8(1):7-9. PubMed ID: 9051742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phentermine+fenfluramine produce cocaine-like discriminative cues.
    Schechter MD; McBurney D
    Life Sci; 1996; 59(20):PL303-8. PubMed ID: 8890951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity.
    Wen PY; Feske SK; Teoh SK; Stieg PE
    Neurology; 1997 Aug; 49(2):632-3. PubMed ID: 9270617
    [No Abstract]   [Full Text] [Related]  

  • 26. Longitudinal effects of fenfluramine-phentermine use.
    Bhattacharyya S; Constantin C; Davar J; Mikhailidis D
    Angiology; 2007 Dec-2008 Jan; 58(6):772-3; author reply 774. PubMed ID: 18216387
    [No Abstract]   [Full Text] [Related]  

  • 27. Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesity.
    Rothman RB
    J Clin Psychiatry; 1996 Feb; 57(2):92-3. PubMed ID: 8591979
    [No Abstract]   [Full Text] [Related]  

  • 28. Dexfenfluramine, fenfluramine, and phentermine for the treatment of morbid obesity.
    Torretta LK
    J Am Acad Nurse Pract; 1997 Aug; 9(8):389-94, quiz 395-7. PubMed ID: 9325813
    [No Abstract]   [Full Text] [Related]  

  • 29. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.
    Kampman KM; Volpicelli JR; Mulvaney F; Rukstalis M; Alterman AI; Pettinati H; Weinrieb RM; O'Brien CP
    Addict Behav; 2002; 27(2):251-60. PubMed ID: 11817766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemoline for the treatment of cocaine dependence in methadone-maintained patients.
    Margolin A; Avants SK; Kosten TR
    J Psychoactive Drugs; 1996; 28(3):301-4. PubMed ID: 8895115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.
    Weintraub M; Sundaresan PR; Schuster B; Ginsberg G; Madan M; Balder A; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):595-601. PubMed ID: 1587073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine.
    Weintraub M; Sundaresan PR; Schuster B; Moscucci M; Stein EC
    Clin Pharmacol Ther; 1992 May; 51(5):602-7. PubMed ID: 1587074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release.
    Kilpatrick IC; Traut M; Heal DJ
    Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1454-8. PubMed ID: 11673765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
    Khan M; Lum CT; Rao V
    Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats.
    Munzar P; Baumann MH; Shoaib M; Goldberg SR
    Psychopharmacology (Berl); 1999 Jan; 141(3):287-96. PubMed ID: 10027510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?
    Park SB; Williamson DJ; Cowen PJ
    Int Clin Psychopharmacol; 1995 Nov; 10(4):215-20. PubMed ID: 8748042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
    Halladay AK; Fisher H; Wagner GC
    Neurotoxicology; 1998 Apr; 19(2):177-83. PubMed ID: 9553954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic interactions between fenfluramine and phentermine.
    Wellman PJ; Maher TJ
    Int J Obes Relat Metab Disord; 1999 Jul; 23(7):723-32. PubMed ID: 10454106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.
    Weintraub M; Sundaresan PR; Madan M; Schuster B; Balder A; Lasagna L; Cox C
    Clin Pharmacol Ther; 1992 May; 51(5):586-94. PubMed ID: 1587072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bipolar depression associated with fenfluramine and phentermine.
    Zimmer JE; Gregory RJ
    J Clin Psychiatry; 1998 Jul; 59(7):383-4. PubMed ID: 9714271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.